Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $2.75 Million - $3.28 Million
-22,553 Reduced 7.81%
266,226 $34.5 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $34.4 Million - $41.4 Million
-281,078 Reduced 49.32%
288,779 $35.8 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $25 Million - $30 Million
-186,779 Reduced 24.69%
569,857 $83.4 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $8.72 Million - $10.7 Million
-67,203 Reduced 8.16%
756,636 $121 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $11.9 Million - $15.2 Million
-94,068 Reduced 10.25%
823,839 $110 Million
Q2 2022

Aug 11, 2022

BUY
$141.59 - $168.66 $23.1 Million - $27.5 Million
162,926 Added 21.58%
917,907 $143 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $17.1 Million - $21.2 Million
-131,873 Reduced 14.87%
754,981 $118 Million
Q4 2021

Feb 10, 2022

BUY
$119.87 - $145.67 $14.1 Million - $17.1 Million
117,616 Added 15.29%
886,854 $113 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $28.9 Million - $41.5 Million
224,488 Added 41.21%
769,238 $100 Million
Q2 2021

Aug 12, 2021

SELL
$160.2 - $186.42 $945,179 - $1.1 Million
-5,900 Reduced 1.07%
544,750 $96.8 Million
Q1 2021

May 12, 2021

BUY
$150.19 - $173.5 $24.3 Million - $28.1 Million
161,785 Added 41.6%
550,650 $90.5 Million
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $4.58 Million - $5.37 Million
32,515 Added 9.12%
388,865 $64.2 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $6.88 Million - $9.4 Million
65,214 Added 22.4%
356,350 $50.8 Million
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $7.67 Million - $9.77 Million
-80,201 Reduced 21.6%
291,136 $32.1 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $874,416 - $1.52 Million
-9,966 Reduced 2.61%
371,337 $37 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $6.01 Million - $7.85 Million
51,076 Added 15.47%
381,303 $56.9 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $243,600 - $278,745
-1,946 Reduced 0.59%
330,227 $42.3 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $8.13 Million - $9.35 Million
64,735 Added 24.21%
332,173 $47.4 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $827,089 - $970,630
6,790 Added 2.61%
267,438 $38.2 Million
Q4 2018

Feb 12, 2019

BUY
$115.94 - $166.74 $5.44 Million - $7.82 Million
46,890 Added 21.94%
260,648 $32.3 Million
Q3 2018

Nov 13, 2018

BUY
$161.01 - $180.57 $7.86 Million - $8.82 Million
48,825 Added 29.6%
213,758 $35.9 Million
Q2 2018

Aug 07, 2018

BUY
$146.33 - $183.18 $1.93 Million - $2.42 Million
13,211 Added 8.71%
164,933 $28.4 Million
Q1 2018

May 09, 2018

SELL
$135.59 - $157.16 $523,377 - $606,637
-3,860 Reduced 2.48%
151,722 $22.9 Million
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $5.29 Million - $6.07 Million
40,330 Added 34.99%
155,582 $20.9 Million
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $2.15 Million - $2.34 Million
15,049 Added 15.02%
115,252 $16.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
100,203
100,203 $15.6 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.